Other languages Spectral Medical Inc.

Equities

EDT

CA8475771033

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-05-10 pm EDT			5-day change	1st Jan Change
0.495 ^CAD	+7.61%		+15.12%	+16.47%

May. 09	Spectral Medical Inc. announced that it expects to receive CAD 8.499564 million in funding	CI
May. 06	Spectral Medical Says 105 Patients Now Enrolled in Tigris Trial	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spectral Medical Inc. Provides Tigris Trial Update	May. 06
Spectral Medical Provides Tigris Trial Update	Apr. 10
Spectral Medical Inc. Announces Board Changes	Apr. 02
Spectral Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Spectral Medical Inc. Provides Update on the Company's Tigris Trial	Feb. 28
Spectral Medical Inc. Announces Amendment and Extension of Exclusive Supply and Distribution Agreement with Baxter Healthcare Corporation	Feb. 21
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients	Feb. 15
Spectral Medical Provides Early February Tigris Trial Update	Feb. 05
Spectral Medical Inc. Provides Early February Tigris Trial Update	Feb. 05
Spectral Medical Provides January Tigris Trial Update	Jan. 30
Spectral Medical Inc. l Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial	Jan. 10
Spectral Medical Inc. Provides November Tigris Trial Update	Dec. 04
Spectral Medical Inc. Announces Publication of Tigris Trial Methods Paper	Nov. 14
Spectral Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Spectral Medical Provided Tigris Trial Update	Nov. 07
Spectral Medical Provides Tigris Trial Update	Nov. 07
Spectral Medical Inc. Announces Opening of Tigris Clinical Trial Site At the Mayo Clinic	23-10-16
Spectral Medical Inc. Provides an Update on the Progress of Its Tigris Trial Including Patient Enrollment	23-10-03
Spectral Medical Inc. Announces Stepping Down of John Nosenzo from It's Board of Directors Due to Health Reasons, Effective October 1, 2023	23-10-02
Spectral Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Spectral Medical Inc.

Equities

EDT

CA8475771033

Other languages

Filters